Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3

By sjmartinez • March 31, 2023

Kim NE, Raghunathan RS, Hughes EG, Longstaff XR, Tseng CH, Li S, Cheung DS, Gofnung YA, Famini P, Wu JX, Yeh MW, Livhits MJ. Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3. J Clin Endocrinol Metab. 2023 Mar 30:dgad181. doi: 10.1210/clinem/dgad181. Epub ahead of print. PMID: 36995878.

Tags: Endocrinology, General Internal Medicine, indeterminate nodules, molecular testing, nonoperative, Publications, surveillance, thyroid, thyroid cancer

RHOT Proteins Link Mitochondrial Motility to Cardiomyocyte Sarcomere Maturation

Froese N, Shymotiuk I, Froese A, Polten F, Jablinski J, Scholz T, Korf-Klingebiel M, Werlein C, Galuppo P, Gigina A, Wihler K, Schneider J, Erschow[...]

Correction: Reaching Veterans Most in Need: Evaluating Engagement in a National Telephone Lifestyle Coaching Program for Veterans

Clair K, Bean-Mayberry B, Chanfreau C, Hurley S, Pear E, Goldstein MG, Kim J, Raffa SD, Moin T, Finley EP, Hamilton A, Farmer MM. Correction:[...]

The liver regulates ectopic calcification in Abcc6-deficient models of Pseudoxanthoma Elasticum

Wang Y, Sun B, Ma F, Tao B, Gu Y, Zhou Z, Kim J, Zhang L, Liu Z, Ten Hoeve J, Stiles L, Fernandez-Del-Rio L,[...]